DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. (DMAC) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 81 transactions totaling $39.3M, demonstrating a bullish sentiment with $32.2M in net insider flow. The most recent transaction on Nov 25, 2025 involved a purchase of 73,099 shares valued at $626.5K.
DMAC Insider Activity Summary
Who Is Buying DMAC Stock?
No significant insider buying has been recorded for DMAC in the recent period.
Who Is Selling DMAC Stock?
No significant insider selling has been recorded for DMAC in the recent period.
Is DiaMedica Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DMAC is bullish with an Insider Alignment Score of 91/100 and a net flow of $32.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DMAC Frequently Asked Questions
Understanding DMAC Insider Activity
Insider trading at DiaMedica Therapeutics Inc. (DMAC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading DMAC stock, having executed 81 transactions in the past 90 days. The most active insider is Koch Thomas Von (Executive), who has made 3 transactions totaling $17.1M.
Related Tools
Track DiaMedica Therapeutics Inc. Insider Activity
Get notified when executives and directors at DMAC file new Form 4 transactions